Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
Authors not listed
New York State Institute for Basic Research · 2002
Abstract
The goal of this study is to determine the safety and efficacy of the administration of vitamin E, which has been shown to delay the progression of Alzheimer's disease, in slowing the rate of cognitive/functional decline in older persons with Down syndrome.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2002). Multicenter Vitamin E Trial in Aging Persons With Down Syndrome. <em>New York State Institute for Basic Research</em>. https://clinicaltrials.gov/study/NCT00056329
Vancouver
Anonymous. Multicenter Vitamin E Trial in Aging Persons With Down Syndrome. New York State Institute for Basic Research. 2002.
BibTeX
@misc{anon2002Multic,
title = {Multicenter Vitamin E Trial in Aging Persons With Down Syndrome},
author = {Anonymous},
journal = {New York State Institute for Basic Research},
year = {2002},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New York State Institute for Basic Research 2000
Open access · US-GOV
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
Seminars in Immunology 2023
Preprint · OA
Immune aging – A mechanism in autoimmune disease
Medical Sciences 2025
Open access · CC-BY
Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan
PubMed 2024
Preprint · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging.
Aging and Disease 2024
Open access · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging
GeroScience 2023
Preprint · OA